Pär Stattin

Active 1997–2025

185
Papers
20,665
Citations
92
h-index
179
i10-index

Citations

Citations per year for Pär Stattin1992: 1 citations1998: 5 citations1999: 6 citations2000: 13 citations2001: 28 citations2002: 40 citations2003: 61 citations2004: 74 citations2005: 101 citations2006: 96 citations2007: 141 citations2008: 150 citations2009: 210 citations2010: 210 citations2011: 273 citations2012: 259 citations2013: 212 citations2014: 231 citations2015: 205 citations2016: 191 citations2017: 167 citations2018: 173 citations2019: 533 citations2020: 610 citations2021: 538 citations2022: 439 citations2023: 326 citations2024: 526 citations2025: 227 citations2026: 5 citations1993–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,994 citing papers, 22.5% of this breakdownChina: 722 citing papers, 8.1% of this breakdownUnited Kingdom: 690 citing papers, 7.8% of this breakdownSweden: 594 citing papers, 6.7% of this breakdownGermany: 438 citing papers, 4.9% of this breakdownItaly: 421 citing papers, 4.7% of this breakdownCanada: 359 citing papers, 4% of this breakdownFrance: 306 citing papers, 3.4% of this breakdownAustralia: 304 citing papers, 3.4% of this breakdownNetherlands: 256 citing papers, 2.9% of this breakdownSpain: 237 citing papers, 2.7% of this breakdownDenmark: 182 citing papers, 2.1% of this breakdown
0%22.5%Other 26.8%

Fields

  • Medicine66.9%
  • Biochemistry, Genetics and Molecular Biology23%
  • Immunology and Microbiology3.2%
  • Neuroscience1.6%
  • Nursing1.5%
  • Chemistry0.7%
  • Other3.1%

Topics

  • Prostate Cancer Treatment and Research8.4%
  • Prostate Cancer Diagnosis and Treatment6.7%
  • Cancer, Lipids, and Metabolism4.4%
  • Cancer Risks and Factors4%
  • Metabolism, Diabetes, and Cancer3.4%
  • Nutritional Studies and Diet1.5%
  • Other71.6%

Coauthors

All papers

Open in search
  1. Epidemiology and Prevention of Prostate Cancer

    Authors: , , , , , , , , - European Urology Oncology 2021 cited by 609

  2. The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers

    Authors: , , , , , , , , , , , , , - International Journal of Epidemiology 2019 cited by 160

  3. Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortality

    Authors: , , , , , , , , , , , , , - Aging Cell 2010 cited by 281

  4. Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study

    Authors: , , , , , , - European Urology 2019 cited by 139

  5. Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project

    Authors: , , , , , , , , , , , , , - Hypertension 2012 cited by 283

  6. Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer

    Authors: , , , , , - Journal of Clinical Oncology 2015 cited by 263

  7. Evaluation of data quality in the National Prostate Cancer Register of Sweden

    Authors: , , , , , - European Journal of Cancer 2014 cited by 140

  8. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert J. MacInnis, Satu Männistö, E. Jeffrey Metter, Kazuya Mikami, Lorelei A. Mucci, Anja Olsen, Kotaro Ozasa, Domenico Palli, Kathryn L. Penney, Elizabeth A. Platz, Michaël Pollak, Monique J. Roobol, Catherine Schaefer, Jeannette M. Schenk, Pär Stattin, Akiko Tamakoshi, Elin Thysell, C. Jillian Tsai, Mathilde Touvier, Stephen K. Van Den Eeden, Elisabete Weiderpass, Stephanie J. Weinstein, Lynne R. Wilkens, Bu B. Yeap, Rosalind A. Eeles, Christopher A. Haiman, Zsofia Kote‐Jarai, Fredrick R. Schumacher, Sara Benlloch, Ali Amin Al Olama, Kenneth Muir, Sonja I Berndt, David V. Conti, Fredrik Wiklund, Stephen Chanock, Ying Wang, Catherine M. Tangen, Jyotsna Batra, Judith A. Clements, Naomi E. Allen, Timothy J. Key, Ruth C. Travis - International Journal of Epidemiology 2022 cited by 56

  9. Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Regional Health - Europe 2024 cited by 48

  10. Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study

    Authors: , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2023 cited by 53

  11. Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hilde Langseth, Gail A. Laughlin, Loı̈c Le Marchand, Tapio Luostarinen, Robert J. MacInnis, Hanna Mäenpää, Satu Männistö, E. Jeffrey Metter, Kazuya Mikami, Lorelei A. Mucci, Anja W. Olsen, Kotaro Ozasa, Domenico Palli, Kathryn L. Penney, Elizabeth A. Platz, Harri Rissanen, Norie Sawada, Jeannette M. Schenk, Pär Stattin, Akiko Tamakoshi, Elin Thysell, C. Jillian Tsai, Shoichiro Tsugane, Lars J. Vatten, Elisabete Weiderpass, Stephanie J. Weinstein, Lynne R. Wilkens, Bu B. Yeap, CRUK, BPC3, CAPS, PEGASUS, Naomi E. Allen, Timothy J. Key, Ruth C. Travis - International Journal of Cancer 2022 cited by 53

  12. Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

    Authors: , , , , , - JAMA Network Open 2023 cited by 34

  13. The Proteome of Primary Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , - European Urology 2015 cited by 187

  14. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults

    Authors: , , , , , , , , , , , , , , , , , - International Journal of Cancer 2011 cited by 179

  15. An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts

    Authors: , , , , , , , , , - Epidemiology 2021 cited by 45

  16. Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival

    Authors: , , , , , , , - PLoS ONE 2011 cited by 488

  17. Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study

    Authors: , , , , , , , - European Urology 2023 cited by 41

  18. Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts

    Authors: , , , , , , , , , , , , - PLoS Medicine 2009 cited by 244

  19. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women

    Authors: , , , , , , , , , , , , , , , , , , , - International Journal of Cancer 2003 cited by 240

  20. Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meir J. Stampfer, Frank Z. Stanczyk, Pär Stattin, Akiko Tamakoshi, Catherine M. Tangen, Ian M. Thompson, Konstantinos K. Tsilidis, Shoichiro Tsugane, Giske Ursin, Lars J. Vatten, Noel S. Weiss, Bu B. Yeap, Naomi E. Allen, Timothy J. Key, Ruth C. Travis - European Urology 2018 cited by 123

  21. Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions

    Authors: , , , , , , , , - Scientific Reports 2015 cited by 94

  22. BMI and weight changes and risk of obesity-related cancers: a pooled European cohort study

    Authors: , , , , , , , , , , , , - International Journal of Epidemiology 2019 cited by 72

  23. Prospective Study of Hyperglycemia and Cancer Risk

    Authors: , , , , , , , - Diabetes Care 2007 cited by 348

  24. Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

    Authors: , , , , , - JAMA Oncology 2016 cited by 168